Primary hyperaldosteronism: diagnosis and treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 8
Abstract
The aspects of primary hyperaldosteronism that have an important social and medical value are examined in this lecture. It is underlined that in some patients with timely diagnosis and choice of optimal therapeutic approach, a complete recovery is possible. In spite of improvement of laboratory and instrumental research methods, drug and surgical treatment, the problem of diagnosis and therapy of primary hyperaldosteronism is still of high relevance. The success of treatment and prognosis in these patients is directly dependent on the alertness of therapists, endocrinologists and cardiologists regarding symptomatic arterial hypertension, from the knowledge of the clinical picture, the tactics of the survey and the approaches to therapy.
Authors and Affiliations
L. A. Nikitiuk, A. M. Kravchenko, V. S. Pasko, A. O. Kovalska
Keywords
Related Articles
- EP ID EP264354
- DOI 10.22141/2224-0721.13.8.2017.119278
- Views 60
- Downloads 0
Benfotiamine and Alpha-Lipoic Acid in the Treatment of Diabetic Cardiovascular Autonomic Neuropathy (Review of Literature and Own Researches)
The analysis of current views on the mechanisms of fat-soluble form of vitamin B1 (benfotiamine) and α-lipoic acid action, in particular features of their impact on carbohydrate and lipid metabolism, endothelial function...
Features of the Parameters of Daily Blood Pressure Monitoring in Patients with Comorbidities of Obesity and Hypertension
In patients with comorbidity of obesity and hypertension disease we have studied the parameters of daily blood pressure monitoring depending on body mass index (BMI) and type of obesity, using default values of BMI over...
General Thyroidology
No abstract
Development Сoncept of Medical Science and Guidelines of Researches in Scientific Institutions of National Academy of Medical Sciences for 2013–2015 (Draft)
.
The Results of Open-Label, Multicenter, Non-Randomized Study on the Efficacy and Safety of Insulins: Insuman Basal®, Insuman Comb 25®, Insuman Rapid® in Patients with Diabetes Mellitus Type 2 Who Underwent Basic Training in Diabetes Schools (SPIRIT)
The objective of this study was to evaluate the level of glycated hemoglobin (HbA1c) reduction after 6 months of treatment with Insuman® insulin in patients with diabetes mellitus type 2 (DM-2), who were not treated with...